" class="no-js "lang="en-US"> Matthew Hayes - Medtech Alert
Thursday, November 07, 2024
Matthew Hayes

Matthew Hayes

About Matthew Hayes

Matthew Hayes is the Chief Technology Officer and current interim CEO of Evonetix, and was a founder member of the team that created the company in 2015.

Before joining Evonetix, Matthew was Head of Technology for the Global Medtech Division of Cambridge Consultants. He joined Cambridge Consultants in 2001, and was responsible for the leadership of many of their largest and most technically challenging projects.

Matthew specialises in multi-disciplinary system design, medical device development, ASIC design and opto-electronics. He holds a PhD and MEng in Electronic Engineering, both from

Related Story

Evonetix Appoints Colin McCracken as Chief Executive Officer

June 14 2022

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced the […]

Evonetix Granted Patent for Binary Assembly Method for Gene Synthesis

May 10 2022

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced it […]

Evonetix Granted Patent for Technology Enabling Thermally-controlled DNA Synthesis

April 4 2022

EVONETIX LTD (‘Evonetix’), the synthetic biology company bringing semiconductor technology to DNA synthesis, today announced […]